TrianglePUBLICATIONS · 28211936
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2017 Jun 15
- First author
- Walterhouse DO
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Walterhouse DO
- type
- Author
- name
- Pappo AS
- type
- Author
- name
- Meza JL
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Hayes-Jordan A
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Cripe TP
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Hawkins DS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Walterhouse DO
- type
- Author
- name
- Pappo AS
- type
- Author
- name
- Meza JL
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Hayes-Jordan A
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Cripe TP
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Hawkins DS
- type
- Author
- bibliography ids
- nci-bib-4fa7191f4cf5bc4cccd2a306
- book metadata
- content sha256
- 1d0f4b324a27959a0105f245da588d059bfe71357bfe292b7b32ebccf6b97d19
- document type
- citation
- dois
- 10.1002/cncr.30613
- electronic publication date
- display
- 2017 Feb 17
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28211936
- immutable id
- pubmed:28211936@1d0f4b324a27959a0105f245da588d059bfe71357bfe292b7b32ebccf6b97d19
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 12
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 2368-2375
- volume
- 123
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28211936
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 9d31f1a13c0fb969eca8e91cbb9355c1f0ddf127b94daab6797c53d1d4da6871
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017 Jun 15
- precision
- day
- year
- 2017
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Preserved source evidence · Not medical advice